Revive Therapeutics Ltd. (RVV.CX)
0.025
0.00 (0.00%)
CAD |
CNSX |
Aug 25, 16:00
Revive Therapeutics Shareholders Equity (Quarterly) : -4.025M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -4.025M |
| December 31, 2025 | -3.74M |
| September 30, 2025 | -3.501M |
| June 30, 2025 | -3.456M |
| March 31, 2025 | 5.942M |
| December 31, 2024 | 6.395M |
| September 30, 2024 | 6.760M |
| June 30, 2024 | 7.232M |
| March 31, 2024 | 9.817M |
| December 31, 2023 | 9.531M |
| September 30, 2023 | 10.26M |
| June 30, 2023 | 10.65M |
| March 31, 2023 | 11.85M |
| December 31, 2022 | 9.514M |
| September 30, 2022 | 11.04M |
| June 30, 2022 | 12.60M |
| March 31, 2022 | 15.10M |
| December 31, 2021 | 21.06M |
| September 30, 2021 | 24.19M |
| June 30, 2021 | 28.81M |
| March 31, 2021 | 31.34M |
| December 31, 2020 | 9.858M |
| September 30, 2020 | 9.368M |
| June 30, 2020 | 7.429M |
| March 31, 2020 | 6.036M |
| Date | Value |
|---|---|
| December 31, 2019 | 0.4851M |
| September 30, 2019 | 0.6595M |
| June 30, 2019 | 0.9608M |
| March 31, 2019 | 1.380M |
| December 31, 2018 | 0.2836M |
| September 30, 2018 | 0.5538M |
| June 30, 2018 | 0.8211M |
| March 31, 2018 | 1.149M |
| December 31, 2017 | 1.266M |
| September 30, 2017 | 1.20M |
| June 30, 2017 | 1.615M |
| March 31, 2017 | 2.032M |
| December 31, 2016 | 1.403M |
| September 30, 2016 | 1.624M |
| June 30, 2016 | 0.5686M |
| March 31, 2016 | 0.2502M |
| December 31, 2015 | 0.7242M |
| September 30, 2015 | 1.493M |
| June 30, 2015 | 2.362M |
| March 31, 2015 | 2.915M |
| December 31, 2014 | 3.304M |
| September 30, 2014 | 1.024M |
| June 30, 2014 | 1.265M |
| March 31, 2014 | 1.612M |
| December 31, 2013 | 1.737M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| HLS Therapeutics, Inc. | 78.37M |
| Bausch Health Cos., Inc. | -2.513B |
| Cipher Pharmaceuticals, Inc. | 194.73M |
| BioSyent, Inc. | 45.84M |
| Knight Therapeutics, Inc. | 798.59M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.2818M |
| Total Liabilities (Quarterly) | 4.306M |
| Debt to Equity Ratio | -0.0176 |
| Current Ratio | 0.0359 |
| Net Debt Paydown Yield | -0.09% |